Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Enzinger

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
European Journal of Neurology|March 21, 2020
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of NeurologyM Mancuso, M Arnold, A Bersano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancerBrian M Wolpin, Aram F Hezel, Thomas Abrams, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosisZ T Kincses, S Ropele, M Jenkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction CancersPeter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, et al.
Cancer|June 23, 2007
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Keith Stuart, Lawrence S Blaszkowsky, et al.
BMJ Open Sport & Exercise Medicine|June 20, 2022
Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility studyJustin C Brown, Elizabeth Brighton, Nancy Campbell, et al.
Journal of Neurology|November 16, 2007
MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findingsA Seewann, C Enzinger, M Filippi, et al.
Investigational New Drugs|July 30, 2011
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancerJason E Faris, Jamie Arnott, Hui Zheng, et al.
European Journal of Neurology|April 24, 2016
Frequency and predictors of acute ischaemic lesions on brain magnetic resonance imaging in young patients with a clinical diagnosis of transient ischaemic attackC Tanislav, U Grittner, F Fazekas, et al.
JCO Clinical Cancer Informatics|November 13, 2025
Pilot Testing of a Multicomponent Cancer Pain-Cognitive Behavioral Therapy mHealth App for Patients With Advanced CancerDesiree R Azizoddin, Sara M DeForge, Jian Zhao, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
European Journal of Neurology|March 21, 2020
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of NeurologyM Mancuso, M Arnold, A Bersano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancerBrian M Wolpin, Aram F Hezel, Thomas Abrams, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosisZ T Kincses, S Ropele, M Jenkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction CancersPeter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, et al.
Cancer|June 23, 2007
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinomaAndrew X Zhu, Keith Stuart, Lawrence S Blaszkowsky, et al.
BMJ Open Sport & Exercise Medicine|June 20, 2022
Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility studyJustin C Brown, Elizabeth Brighton, Nancy Campbell, et al.
Journal of Neurology|November 16, 2007
MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findingsA Seewann, C Enzinger, M Filippi, et al.
Investigational New Drugs|July 30, 2011
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancerJason E Faris, Jamie Arnott, Hui Zheng, et al.
European Journal of Neurology|April 24, 2016
Frequency and predictors of acute ischaemic lesions on brain magnetic resonance imaging in young patients with a clinical diagnosis of transient ischaemic attackC Tanislav, U Grittner, F Fazekas, et al.
JCO Clinical Cancer Informatics|November 13, 2025
Pilot Testing of a Multicomponent Cancer Pain-Cognitive Behavioral Therapy mHealth App for Patients With Advanced CancerDesiree R Azizoddin, Sara M DeForge, Jian Zhao, et al.
Pageof 20